Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

ETAO International (ETAO) Competitors

ETAO International logo

ETAO vs. HIMS, TDOC, AUNA, SBC, AIRS, LFMD, TOI, SHLT, CCM, and CMRA

Should you be buying ETAO International stock or one of its competitors? The main competitors of ETAO International include Hims & Hers Health (HIMS), Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), AirSculpt Technologies (AIRS), LifeMD (LFMD), Oncology Institute (TOI), SHL Telemedicine (SHLT), Concord Medical Services (CCM), and Comera Life Sciences (CMRA).

ETAO International vs.

Hims & Hers Health (NYSE:HIMS) and ETAO International (NASDAQ:ETAO) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Hims & Hers Health presently has a consensus target price of $37.23, indicating a potential upside of 9.50%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than ETAO International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.27
ETAO International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Hims & Hers Health has a net margin of 8.19% compared to ETAO International's net margin of 0.00%. Hims & Hers Health's return on equity of 10.97% beat ETAO International's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health8.19% 10.97% 8.29%
ETAO International N/A N/A N/A

Hims & Hers Health received 43 more outperform votes than ETAO International when rated by MarketBeat users.

CompanyUnderperformOutperform
Hims & Hers HealthOutperform Votes
43
37.39%
Underperform Votes
72
62.61%
ETAO InternationalN/AN/A

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 0.2% of ETAO International shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 20.8% of ETAO International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Hims & Hers Health has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, ETAO International has a beta of 1.92, indicating that its share price is 92% more volatile than the S&P 500.

Hims & Hers Health has higher revenue and earnings than ETAO International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.48B5.12-$23.55M$0.5462.96
ETAO International$58.89M0.00-$896.68MN/AN/A

In the previous week, Hims & Hers Health had 40 more articles in the media than ETAO International. MarketBeat recorded 40 mentions for Hims & Hers Health and 0 mentions for ETAO International. Hims & Hers Health's average media sentiment score of 0.44 beat ETAO International's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company Overall Sentiment
Hims & Hers Health Neutral
ETAO International Neutral

Summary

Hims & Hers Health beats ETAO International on 12 of the 14 factors compared between the two stocks.

Remove Ads
Get ETAO International News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETAO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ETAO vs. The Competition

MetricETAO InternationalOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$2,000.00$1.17B$5.64B$8.08B
Dividend YieldN/AN/A4.89%4.04%
P/E RatioN/A15.4523.7319.00
Price / SalesN/A1.17381.75120.61
Price / CashN/A36.0138.0534.64
Price / BookN/A9.116.904.26
Net Income-$896.68M-$52.07M$3.18B$247.00M

ETAO International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ETAO
ETAO International
N/AN/AN/AN/A$2,000.00$58.89M0.003,600
HIMS
Hims & Hers Health
2.4936 of 5 stars
$40.62
-0.2%
$37.23
-8.3%
+139.6%$9.02B$1.48B92.311,046Gap Up
TDOC
Teladoc Health
3.2759 of 5 stars
$9.21
-2.4%
$11.26
+22.4%
-42.3%$1.60B$2.57B-1.605,600
AUNA
Auna
3.7738 of 5 stars
$7.81
+1.5%
$13.53
+73.3%
N/A$576.93M$4.34B0.0014,958News Coverage
SBC
SBC Medical Group
N/A$4.66
+1.3%
N/AN/A$480.08M$223.34M0.00N/A
AIRS
AirSculpt Technologies
1.2875 of 5 stars
$3.95
-2.5%
$5.00
+26.6%
-49.8%$228.63M$188.78M-28.21240News Coverage
Positive News
Gap Down
LFMD
LifeMD
1.9972 of 5 stars
$4.86
+2.7%
$11.14
+129.3%
-29.9%$210.50M$193.06M-7.59230Earnings Report
Analyst Forecast
Short Interest ↑
News Coverage
Gap Up
TOI
Oncology Institute
0.6996 of 5 stars
$0.69
-4.7%
N/A-61.8%$52.15M$378.93M-0.88660Positive News
Gap Up
SHLT
SHL Telemedicine
1.7439 of 5 stars
$2.40
-4.0%
$11.00
+358.3%
-61.9%$39.34M$55.94M0.00583News Coverage
Gap Down
CCM
Concord Medical Services
0.5524 of 5 stars
$4.98
-4.1%
N/A+4.7%$21.60M$471.70M0.00970Short Interest ↑
News Coverage
CMRA
Comera Life Sciences
N/A$0.00
flat
N/A-99.6%$6,000.00$1.00M0.002
Remove Ads

Related Companies and Tools


This page (NASDAQ:ETAO) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners